These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 29709975

  • 1. Isolation of an Egg-Adapted Influenza A(H3N2) Virus without Amino Acid Substitutions at the Antigenic Sites of Its Hemagglutinin.
    Kuwahara T, Takashita E, Fujisaki S, Shirakura M, Nakamura K, Kishida N, Takahashi H, Suzuki N, Kawaoka Y, Watanabe S, Odagiri T.
    Jpn J Infect Dis; 2018 May 24; 71(3):234-238. PubMed ID: 29709975
    [Abstract] [Full Text] [Related]

  • 2. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
    Zost SJ, Parkhouse K, Gumina ME, Kim K, Diaz Perez S, Wilson PC, Treanor JJ, Sant AJ, Cobey S, Hensley SE.
    Proc Natl Acad Sci U S A; 2017 Nov 21; 114(47):12578-12583. PubMed ID: 29109276
    [Abstract] [Full Text] [Related]

  • 3. Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses.
    Parker L, Wharton SA, Martin SR, Cross K, Lin Y, Liu Y, Feizi T, Daniels RS, McCauley JW.
    J Gen Virol; 2016 Jun 21; 97(6):1333-1344. PubMed ID: 26974849
    [Abstract] [Full Text] [Related]

  • 4. The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response.
    Chen Z, Zhou H, Jin H.
    Vaccine; 2010 May 28; 28(24):4079-85. PubMed ID: 20399830
    [Abstract] [Full Text] [Related]

  • 5. Antigenic assessment of the H3N2 component of the 2019-2020 Northern Hemisphere influenza vaccine.
    Gouma S, Weirick M, Hensley SE.
    Nat Commun; 2020 May 15; 11(1):2445. PubMed ID: 32415074
    [Abstract] [Full Text] [Related]

  • 6. Preventing an Antigenically Disruptive Mutation in Egg-Based H3N2 Seasonal Influenza Vaccines by Mutational Incompatibility.
    Wu NC, Lv H, Thompson AJ, Wu DC, Ng WWS, Kadam RU, Lin CW, Nycholat CM, McBride R, Liang W, Paulson JC, Mok CKP, Wilson IA.
    Cell Host Microbe; 2019 Jun 12; 25(6):836-844.e5. PubMed ID: 31151913
    [Abstract] [Full Text] [Related]

  • 7. Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.
    Wang X, Ilyushina NA, Lugovtsev VY, Bovin NV, Couzens LK, Gao J, Donnelly RP, Eichelberger MC, Wan H.
    J Virol; 2017 Jan 15; 91(2):. PubMed ID: 27807224
    [Abstract] [Full Text] [Related]

  • 8. Egg-adaptive mutations in H3N2v vaccine virus enhance egg-based production without loss of antigenicity or immunogenicity.
    Barman S, Franks J, Turner JC, Yoon SW, Webster RG, Webby RJ.
    Vaccine; 2015 Jun 22; 33(28):3186-92. PubMed ID: 25999284
    [Abstract] [Full Text] [Related]

  • 9. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.
    Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA, Fonseca K, Winter AL, Gubbay JB, Krajden M, Petric M, Charest H, Bastien N, Kwindt TL, Mahmud SM, Van Caeseele P, Li Y.
    PLoS One; 2014 Jun 22; 9(3):e92153. PubMed ID: 24667168
    [Abstract] [Full Text] [Related]

  • 10. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics.
    Lu B, Zhou H, Ye D, Kemble G, Jin H.
    J Virol; 2005 Jun 22; 79(11):6763-71. PubMed ID: 15890915
    [Abstract] [Full Text] [Related]

  • 11. A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine.
    Wu NC, Zost SJ, Thompson AJ, Oyen D, Nycholat CM, McBride R, Paulson JC, Hensley SE, Wilson IA.
    PLoS Pathog; 2017 Oct 22; 13(10):e1006682. PubMed ID: 29059230
    [Abstract] [Full Text] [Related]

  • 12. Antigenic characterization of influenza viruses produced using synthetic DNA and novel backbones.
    Suphaphiphat P, Whittaker L, De Souza I, Daniels RS, Dormitzer PR, McCauley JW, Settembre EC.
    Vaccine; 2016 Jul 12; 34(32):3641-8. PubMed ID: 27219338
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of Next-Generation H3 Influenza Vaccines in Ferrets Pre-Immune to Historical H3N2 Viruses.
    Allen JD, Ross TM.
    Front Immunol; 2021 Jul 12; 12():707339. PubMed ID: 34475872
    [Abstract] [Full Text] [Related]

  • 14. Genetic characterization of seasonal influenza A (H3N2) viruses in Ontario during 2010-2011 influenza season: high prevalence of mutations at antigenic sites.
    Eshaghi A, Duvvuri VR, Li A, Patel SN, Bastien N, Li Y, Low DE, Gubbay JB.
    Influenza Other Respir Viruses; 2014 Mar 12; 8(2):250-7. PubMed ID: 24313991
    [Abstract] [Full Text] [Related]

  • 15. Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity.
    Hervé PL, Lorin V, Jouvion G, Da Costa B, Escriou N.
    Virology; 2015 Dec 12; 486():134-45. PubMed ID: 26433051
    [Abstract] [Full Text] [Related]

  • 16. Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells.
    Katz JM, Webster RG.
    J Gen Virol; 1992 May 12; 73 ( Pt 5)():1159-65. PubMed ID: 1588320
    [Abstract] [Full Text] [Related]

  • 17. The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017.
    Catani JPP, Smet A, Ysenbaert T, Vuylsteke M, Bottu G, Mathys J, Botzki A, Cortes-Garcia G, Strugnell T, Gomila R, Hamberger J, Catalan J, Ustyugova IV, Farrell T, Stegalkina S, Ray S, LaRue L, Saelens X, Vogel TU.
    Elife; 2024 May 28; 12():. PubMed ID: 38805550
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs.
    Kishida N, Fujisaki S, Yokoyama M, Sato H, Saito R, Ikematsu H, Xu H, Takashita E, Tashiro M, Takao S, Yano T, Suga T, Kawakami C, Yamamoto M, Kajiyama K, Saito H, Shimada S, Watanabe S, Aoki S, Taira K, Kon M, Lin JH, Odagiri T.
    Clin Vaccine Immunol; 2012 Jun 28; 19(6):897-908. PubMed ID: 22492743
    [Abstract] [Full Text] [Related]

  • 19. The characteristics and antigenic properties of recently emerged subclade 3C.3a and 3C.2a human influenza A(H3N2) viruses passaged in MDCK cells.
    Lin Y, Wharton SA, Whittaker L, Dai M, Ermetal B, Lo J, Pontoriero A, Baumeister E, Daniels RS, McCauley JW.
    Influenza Other Respir Viruses; 2017 May 28; 11(3):263-274. PubMed ID: 28164446
    [Abstract] [Full Text] [Related]

  • 20. Single hemagglutinin mutations that alter both antigenicity and receptor binding avidity influence influenza virus antigenic clustering.
    Li Y, Bostick DL, Sullivan CB, Myers JL, Griesemer SB, Stgeorge K, Plotkin JB, Hensley SE.
    J Virol; 2013 Sep 28; 87(17):9904-10. PubMed ID: 23824816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.